Bullishcharts

Arcus Biosciences on hot watch for breakout.

NYSE:RCUS   Arcus Biosciences, Inc
Arcus Biosciences , Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

⭐Email Newsletter > https://BullishCharts.com/

🔵Telegram Channel > https://t.me/BullishCharts
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.